Expert Voices

Commercial Biomanufacturing with Single-Use Technologies

Jan Schäfer Sartorius Stedim Biotech (January 2018)

Accelerating the Commercialization of Biosimilar Medicines in India

Predictability of mAb & ADC commercialization

Dr. Nick Hutchinson

Interview: Continuous Bioprocessing

Fritjof Linz, Vice President Purification Technologies, Sartorius-Stedim Biotech

Interview: Perfusion Cell Culture Processes in at WuXi in China

Dr Weichang Zhou, Senior Vice President, Biologics Development and Manufacturing, WuXi Biologics Inc.

Interview: Continuous and Intensified Bioprocessing

Dr. Gerben Zijlstra

Bioprocess Development Engineering

We provide a unique implementation methodology for your bioprocess using SU technologies and hybrid solutions for your type & scale of process.

Biopharmaceutical Manufacturing

Instrument Services